|
Originally published In Press as doi:10.1074/jbc.M101379200 on April 3, 2001
J. Biol. Chem., Vol. 276, Issue 26, 23221-23229, June 29, 2001
Isolation and Characterization of Major Glycoproteins of Pigeon
Egg White
UBIQUITOUS PRESENCE OF UNIQUE N-GLYCANS CONTAINING
Gal 1-4Gal*
Noriko
Suzuki ,
Kay-Hooi
Khoo§,
Hao-Chia
Chen¶,
James R.
Johnson , and
Yuan C.
Lee **
From the Department of Biology, The Johns Hopkins
University, Baltimore, Maryland 21218, the § Institute of
Biological Chemistry, Academia Sinica, Taipei, 115, Taiwan, the
¶ Endocrinology and Reproduction Research Branch, NICHD, National
Institutes of Health, Bethesda, Maryland 20892, and the Veterans
Affairs Medical Center and Department of Medicine, University of
Minnesota, Minneapolis, Minnesota 55417
Received for publication, February 13, 2001, and in revised form, March 21, 2001
 |
ABSTRACT |
Ovotransferrin (POT), two ovalbumins (POA(hi) and
POA(lo)), and ovomucoid (POM) were isolated from pigeon egg white
(PEW). Unlike their chicken egg white counterparts, PEW glycoproteins contain terminal Gal 1-4Gal, as evidenced by GS-I lectin (specific for terminal -Gal), anti-P1
(Gal 1-4Gal 1-4GlcNAc 1-3Gal 1-4Glc 1-1Cer) monoclonal
antibody, and P fimbriae on uropathogenic Escherichia coli
(specific for Gal 1-4Gal). Gal 1-4Gal on PEW glycoproteins were
found in N-glycans releasable by treatment with
glycoamidase F. The respective contents of N-glycans in
each glycoprotein were 3.5%, POT; 17%, POA(hi); and 31-37%, POM.
POA(hi) has four N-glycosylation sites, in contrast to
chicken ovalbumin, which has only one. High performance liquid
chromatography analysis showed that N-glycans on POA(hi)
were highly heterogeneous. Mass spectrometric analysis revealed that
the major N-glycans were monosialylated tri-, tetra-, and
penta-antennary oligosaccharides containing terminal Gal 1-4Gal with
or without bisecting N-acetylglucosamine. Oligosaccharide chains terminating in Gal 1-4Gal are rare among
N-glycans from the mammals and avians that have been
studied, and our finding is the first predominant presence of
(Gal 1-4Gal)-terminated N-glycans.
 |
INTRODUCTION |
In mammals, e.g. human, pig, rat, mouse,
and hamster, Gal 1-4Gal is normally found in the terminal and
internal positions of glycolipids (1-5), as in P1
(Gal 1-4Gal 1-4GlcNAc 1-3Gal 1-4Glc 1-1Cer), Pk (Gal 1-4Gal 1-4Glc 1-1Cer) antigens, and
disialosyl galactosyl globoside
(NeuAc 2-3Gal 1-3(NeuAc 2-3)GalNAc 1-3Gal 1-4Gal 1-4Glc 1-1Cer) (6-8). The glycolipids containing Gal 1-4Gal are known as targets on host cells for infections of some pathogenic microbes,
e.g. uropathogenic Escherichia coli (9, 10),
Pseudomonas aeruginosa (PA-I lectin) (11), and
Streptococcus suis (12-14). Bacterial enterotoxins,
e.g. from E. coli (verotoxin) (15),
Shigella dysenteriae Type 1 (Shiga toxin) (16), and
Staphylococcus aureus (enterotoxin B) also specifically bind
to these glycolipids (17). In contrast, glycoproteins with
Gal 1-4Gal were found only when the mammals were infected by
tapeworm Echnococcus granulosus, in hydatid cyst fluid and
membrane caused by the infection (18-20).
However, ovomucoids produced in pigeon (Columba livia) and
turtle doves (Streptopelia resoria) possess high level of
P1 antigenic activity (21-24). Pigeon ovomucoid
(POM),1 one of the major
glycoproteins in pigeon egg white (PEW), was also found to bind some
pathogenic microbes, e.g. uropathogenic E. coli
(24-26) and S. suis (12-14). Moreover, POM had been
recently utilized for isolation of Shiga-like toxin type 1 (27).
Although the presence of Gal 1-4Gal on ovomucoids of turtle dove and
pigeon has been evidenced and these glycoproteins can be utilized for the study of microbiology, complete carbohydrate structures of these
ovomucoids are not yet known. Only a tentative structure had been
proposed for the main oligosaccharide structure of turtle dove
ovomucoid, which includes Gal 1-4Gal sequence at the non-reducing terminus of the N-glycan (28, 29).
The presence of Gal 1-4Gal on glycoproteins is rare among modern
birds and mammals that have been studied. For example, no oligosaccharides from chicken, quail, or duck ovomucoid (30-34) contain Gal 1-4Gal structure. Whole chicken egg white (CEW) failed to inhibit hemagglutination of P1 erythrocytes by
P-fimbriated uropathogenic E. coli, whereas PEW inhibited it
successfully (24). The presence and absence of Gal 1-4Gal in various
avian egg whites exemplifies the evolutionary diversity of
glycoconjugates among birds. Investigating the relationships between
phylogeny of birds and distribution of oligosaccharides with
Gal 1-4Gal should help us understand how and why this unique
structural feature in the N-glycans has appeared during evolution.
In this study, we examined the major pigeon egg white glycoproteins for
the presence of Gal 1-4Gal, and discovered that not only ovomucoid,
but also major glycoproteins including two ovalbumins and
ovotransferrin, possess N-glycan with terminal
Gal 1-4Gal. Structures of major oligosaccharides from POA(hi) were
determined by mass spectrometric analysis as novel type
N-glycans containing Gal 1-4Gal.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Pigeon eggs were collected from local racing
pigeon breeders in the Minneapolis-St. Paul, MN metropolitan areas, and
egg white and egg yolk were separated manually. Egg white was
lyophilized and kept at 4 °C until use. -Galactosidase from green
coffee beans, alkaline phosphatase-conjugated goat anti-mouse IgM, and mouse laminin from basement membranes were purchased from Sigma. Glycoamidase F2 (GAF; 1 unit
of GAF is the activity that hydrolyzes 1 nmol of dansyl fetuin
glycopeptide in 1 min at 37 °C at pH 7.2) was from Roche Molecular
Biochemicals. Alkaline phosphatase-conjugated GS-I lectin was purchased
from EY Laboratories, Inc. (San Mateo, CA) and anti-P1 mAb
(mouse IgM) was from Gamma Biologicals, Inc. (Houston, TX).
Anti-(Gal 1-3Gal) monoclonal antibody (M86, mouse IgM) (35) was a
kind gift from Dr. Galili (Allegheny University of the Health Sciences,
Philadelphia, PA) and human anti-(Gal 1-3Gal) polyclonal antibody
purified by (Gal 1-3Gal)-immobilized Sepharose was a kind gift from
Dr. George Wang (Wayne State University, Detroit, MI). C4 columns for
reverse phase HPLC (Jupiter 5-µm C4 300A, 4.6 × 250 mm and
Jupiter 10-µm C4 300A, 21.2 × 250 mm) were from Phenomenex
(Torrance, CA), and a C4 column for peptide-purification (300-Å pore
size, 4.6 × 250 mm) was from Vydac (Hesperia, CA). TSKgel
DEAE-5PW column (7.5 × 75 mm) and TSKgel Amido-80 column (4.6 × 250 mm) were from TosoHaas (Montgomeryville, PA), and
YMC-Pak HRC-ODS-A column (6.0 × 150 mm) was from Waters Co.
(Milford, MA). CarboPac PA-1 column (4 × 250 mm) and BioLC with a
pulsed amperometric detector (PAD) for high performance anion exchange chromatography (HPAEC) were from Dionex (Sunnyvale, CA). Polyvinylidene difluoride (PVDF) membranes for blotting were from Millipore (Bedford, MA). Neuraminidase from Arthrobacter ureafaciens was a
generous gift from Dr. Tsukada and Dr. Ohta of Marukin Shoyu Co. (Uji, Japan). Extracti-Gel®D detergent removing gel were from Pierce.
Buffers--
TBS contains 50 mM Tris·HCl (pH 7.4)
and 150 mM NaCl. TBST contains 0.1% Tween 20 in TBS.
Lectin Buffer 1 was TBS containing 1 mM CaCl2
and 1 mM MgSO4, and Lectin Buffer 2 was 100 mM Tris·HCl (pH 9.5) containing 150 mM NaCl
and 5 mM MgCl2.
Isolation of Major Glycoproteins from Pigeon Egg White by
HPLC--
Lyophilized pigeon egg white (200 mg) was dissolved with 1.5 ml of distilled water and centrifuged to remove insoluble materials. Supernatant was filtered through a 0.45-µm membrane and injected onto
a C4 column for HPLC (2 mg for C4 column of 4.6 × 250 mm, 20 mg
for C4 column of 21.2 × 250 mm). The mobile phase was A (0.05%
trifluoroacetic acid) and B (90% CH3CN in H2O
containing 0.05% trifluoroacetic acid). The elution (1 ml/min for
4.6-mm C4 column, 8 ml/min for 21.2-mm C4 column) was by a linear
gradient of 10-70% of B in A developed over 30 min, followed by
isocratic elution for 10 min. Proteins eluted were detected by
A280 nm. Individual peaks were collected,
dialyzed against water in the cold, and then lyophilized.
SDS-PAGE, GS-I Lectin Blotting, and
Immunoblotting--
Glycoproteins from pigeon egg white were heated at
100 °C for 10 min with 3% SDS and 5% (v/v) 2-mercaptoethanol and
separated on 12.5% polyacrylamide gels (36), then transferred to PVDF membrane in 25 mM Tris-glycine (pH 8.3) in 15% methanol.
After blocking with 3% BSA with 0.1% NaN3 overnight, the
membranes were washed three times with TBST and once with Lectin Buffer
1, then incubated with 1 ml of alkaline phosphatase-conjugated GS-I
lectin (1 µg/ml) for 1.5 h. After washing three times with TBST,
5 ml of Lectin Buffer 2 containing 100 µg/ml nitro blue tetrazolium and 200 µg/ml 5-bromo-4-chloro-3-indolyl phosphate was applied to the
membranes to visualize the bound GS-I, then washed three times with
H2O. For immunoblotting with anti-P1 mAb or
anti-(Gal 1-3Gal) mAb (mouse IgM), the transferred membranes were
blocked with 3% BSA containing 0.1% NaN3 overnight,
washed three times with TBST, and incubated with the first antibody for
1.5 h. The membranes were washed with TBST and incubated with the
second antibody, alkaline phosphatase-conjugated goat anti-mouse IgM,
for 1.5 h. After washing with TBST, the bound antibody was
visualized as described above.
Hemagglutination Assay and Measurement of Inhibitory
Activity--
For bacterial or lectin agglutination assays, 3 µl of
a suspension of P-fimbriated E. coli strain J96 (~1 × 1011 colony-forming units/ml in 5% methyl
-D-mannopyranoside in PBS) or 3 µl of GS-I lectin (1 mg/ml in 10 mM phosphate, 0.15 M NaCl, 0.5 mM CaCl2, pH 7.4), 3 µl of inhibitors of
various concentrations or 30 mg/ml BSA in PBS, and then 1 µl of a 5%
(v/v) suspension of human P1-phenotype RBCs in PBS were
mixed on microscope slides. The slides were rocked for 60 s, and
agglutination of RBCs was observed microscopically. Inhibitors were
tested at serial 2-fold dilutions to determine the dilution beyond
which inhibition first dropped to below 100% ("last full
inhibition") and where it was first completely absent ("first full
agglutination"). For the anti-P1 assays, 20 µl of the
anti-P1 mAb and 20 µl of inhibitors or 30 mg/ml BSA in
PBS were mixed in test tubes and incubated for 15 min on ice. Then, 20 µl of a 5% (v/v) suspension of human P1-phenotype RBCs
were added and incubated for 30 min on ice. The cells were spun down to
a pellet and gently resuspended by rocking the tube, then scored for
presence or absence and degree of RBC agglutination. Serial 10-fold
dilutions of each inhibitor were tested in the anti-P1
assays to determine the last dilution still showing inhibition of hemagglutination.
Protein Sequence Analysis--
PEW glycoproteins were separated
by SDS-PAGE and followed by low voltage electroblotting to PVDF
membrane in 10 mM CAPS, pH 11, in 10% methanol, and
subjected to sequencing. N-terminal sequence analysis was carried out
by Edman degradation using a PerkinElmer Life Sciences/Applied
Biosystems model 494 Procise® protein sequencer. Sequence
identity search was performed using SWISS-PROT data base (updated July
25, 1999) interfaced with the Wisconsin Package of the Genetics
Computer Group. Primary accession numbers for the data base are as
follows: chicken ovomucoid, P01005; chicken ovotransferrin, P02789;
chicken ovalbumin, P01012.
Cyanogen Bromide Cleavage and Fragment Purification--
Since
the N termini of both forms of POA (53 and 49 kDa by SDS-PAGE) are
blocked, these proteins were submitted to chemical cleavage by BrCN in
70% formic acid at 37 °C for 4 h. Following the cleavage, the
mixture was diluted 10-fold with distilled water and the solution was
freeze-dried. A single fragment from each POA was isolated either by
reverse phase HPLC on a Vydac C4 column eluted with a linear gradient
of acetonitrile (from 8% to 48% developed over 16 min, 0.5 ml/min) in
0.1% trifluoroacetic acid at 40 °C, and subjected to N-terminal
amino acid sequencing.
Monosaccharide Composition Analysis--
Glycoproteins (20 µg
of POM, 100 µg each of POT, POA(hi), and POA(lo)) were hydrolyzed
with 2 M trifluoroacetic acid to release neutral sugars or
with 4 M HCl to release amino sugars (37). The released
monosaccharides were analyzed with HPAEC-PAD using a CarboPac PA-1
column and isocratic elution with 18 mM NaOH. To release
terminal -linked galactose specifically, glycoproteins were
incubated at 25 °C overnight with coffee bean -galactosidase (15 milliunits) in 100 mM citrate-phosphate buffer (pH 6.5),
and the released galactose was measured with HPAEC-PAD under the same conditions as above. Sialic acids were released from glycoproteins with
sialidase from A. ureafaciens (1 milliunit) by incubating in
50 mM sodium acetate (pH 5.6) at 37 °C for 2 h, and
analyzed with HPAEC-PAD using a CarboPac PA-1 column and isocratic
condition with 100 mM sodium acetate and 100 mM NaOH.
GAF Treatment of PEW Glycoproteins--
Glycoproteins (100 µg)
were dissolved with 25 µl of 0.5% SDS and heated at 90 °C for 3 min to denature. After the solutions were cooled to room temperature,
80 mM sodium phosphate buffer (pH 8.6), 1% (v/v) Nonidet
P-40, and 1 unit of GAF were added to the heat-denatured glycoproteins.
The reaction mixtures (100 µl each) were incubated at 37 °C for
16 h to complete de-N-glycosylation, and heated at
100 °C for 5 min to inactivate GAF. For partial de-N-glycosylation on POA(hi), glycoproteins were incubated
with 0.4 units of GAF for 5 min, 40 min, and 3 h, and heated at
100 °C for 5 min.
To release N-glycans from POM completely, POM was
heat-denatured with 0.5% SDS and 100 mM 2-mercaptoethanol
at 90 °C for 3 min, to which 1% (w/v) CHAPS was added instead of
Nonidet P-40, and incubated with GAF at 37 °C overnight. This
reaction mixture was heat-denatured again at 90 °C for 3 min, and
incubated at 37 °C overnight after adding CHAPS to 1% (w/v) and 1 unit of GAF again. This step had to be repeated three times to achieve
complete deglycosylation of POM, as determined by SDS-PAGE. Detergents in the reaction mixture were removed by gel filtration with
Extracti-Gel®D detergent removing gel.
Matrix-assisted Laser Desorption/Ionization (MALDI-TOF) Mass
Spectrometry--
MALDI-TOF mass spectrometry was performed using a
PerSeptive Biosystems STR BiospectrometryTM research station coupled
with a Delayed ExtractionTM laser-desorption mass spectrometer. An
aliquot of each sample was diluted with 0.1% trifluoroacetic acid and analyzed using matrix of 3,5-dimethoxy-4-hydroxycinnamic acid (sinapinic acid). In some cases in which signals were weak, a portion
of the sample was further purified using a C8 cartridge (1 × 10 mm). After washing with 0.1% trifluoroacetic acid, protein was eluted
with 90% acetonitrile in 0.1% trifluoroacetic acid and analyzed in
the same matrix.
Isolation of Major Oligosaccharides from Pigeon Ovalbumin (High)
by HPLC--
Procedures for isolation of N-linked
oligosaccharides, pyridylamine (PA)-derivatization, and HPLC analysis
were based on the methods established by Tomiya et al. (38,
39) and modified as follows. POA(hi) (100 mg) was digested with 1 mg
each of trypsin and chymotrypsin in 1.5 ml of TBS (pH 7.3) containing 5 mM CaCl2 at 37 °C for 16 h, and then
heated at 100 °C for 10 min. The same amounts of trypsin and
chymotrypsin were added, and the digestion and heat denaturation was
repeated once more. Oligosaccharides were released from the resultant
glycopeptides with 20 units of GAF in the same buffer at 37 °C for
16 h. The residual peptides were digested to amino acids or very
short peptides by incubating with 1 mg of Pronase in the same buffer at
55 °C for 16 h, and the oligosaccharide fractions were
separated by gel filtration on a Sephadex G-50 column (2.5 × 98 cm) in water. For the PA derivatization by reductive amination,
lyophilized oligosaccharide fractions were dissolved in 80 µl of
2-aminopyridine solution (1 g/580 µl in concentrated HCl, pH 6.8),
and heated at 90 °C for 15 min with heating block. Freshly prepared
NaCNBH3 solution (14 mg/8 µl) was added into the reaction
mixture, then heated at 90 °C for 1 h. PA-oligosaccharides were
fractionated by gel filtration on a Sephadex G-15 column (1.0 × 40 cm, in 10 mM NH4HCO3) and
lyophilized. The PA-oligosaccharides were purified by HPLC with three
different columns. In the first step, the PA-oligosaccharide mixture
was separated on a TSKgel DEAE-5PW column (7.5 × 75 mm) as
described previously (39), and the neutral, monosialyl, disialyl,
trisialyl, and tetrasialyl fractions were collected separately and
lyophilized. In the second step, monosialylated oligosaccharides were
separated on a YMC-Pak HRC-ODS-A column (6.0 × 150 mm). Elution
was performed at a flow rate of 1.0 ml/min at 55 °C using Eluent A
(0.005% trifluoroacetic acid) and Eluent B (0.5% 1-butanol in Eluent
A). The column was equilibrated with a mixture of Eluents A and B
(80:20, v/v), and after injection of a sample, the ratio of the eluents
was increased linearly to A:B = 50:50 in 60 min. Each peak was
collected and lyophilized. In the third step, major peaks from ODS
column were further separated on a TSKgel Amido-80 column (4.6 × 250 mm) as described previously (38). In all the HPLC systems,
PA-oligosaccharides were monitored by fluorescence using excitation and
emission wavelengths of 310 and 400 nm, respectively.
Permethylation, Fast Atom Bombardment (FAB)- and Electrospray
(ESI)-Mass Spectrometry (MS) Analyses--
PA-oligosaccharides were
permethylated using the NaOH/dimethyl sulfoxide slurry method as
described by Dell et al. (40). FAB- and ESI-MS analyses were
performed on an Autospec orthogonal acceleration-TOF mass spectrometer
(Micromass), fitted with a magnet bypass flight tube, and
interchangeable FAB and ESI source assemblies. For FAB-MS experiments,
the fitted cesium ion gun was operated at 26 kV and the source
accelerating voltage at 8 kV. Operation in the magnet bypass mode
allowed an acquisition of up to a mass range of m/z 7000 with the fitted TOF detector. Cesium iodide was used as external
calibrant for both the magnet and TOF mass analyzers. The permethyl
derivatives of the N-glycans were redissolved in
CH3OH for loading onto the probe tip coated with
glycerol:m-nitrobenzyl alcohol:trifluoroacetic acid
(50:50:1, v/v/v) as matrix. Collision-induced dissociation (CID)
FAB-MS/MS was performed by introducing argon gas to the collision cell
to a reading of ~1.2 × 10 6 millibars
on the TOF ion gauge, at a lab frame collision energy of 800 eV and a
push-out frequency of 56 kHz for orthogonal sampling. A 1-s integration
time per spectrum was chosen for the TOF analyzer with a 0.1-s
interscan delay. Individual spectra were summed for data processing.
For ESI-MS, the accelerating voltage was maintained at 4 kV, which
allowed magnet scanning above the mass range of m/z 5000. Hall probe calibration was used. The permethyl derivatives were
dissolved in CH3OH, and 10-µl aliquots were injected
through a Rheodyne loop into the mobile phase (methanol:water:acetic
acid, 50:50:1, v/v/v), delivered at a flow rate of 5 µl/min into the ESI source by a syringe pump.
Linkage Analysis--
For gas chromatography (GC)-electron
impact (EI)-MS linkage analysis, partially methylated alditol acetates
were prepared from the permethyl derivatives by hydrolysis (2 M trifluoroacetic acid, 121 °C, 2 h), reduction (10 mg/ml NaBH4, 25 °C, 2 h), and acetylation (acetic
anhydride, 100 °C, 1 h). GC-EI-MS was carried out using a
Hewlett-Packard Gas Chromatograph 6890 connected to a Hewlett-Packard
Mass Selective Detector 5973. Sample was dissolved in hexane prior to
splitless injection into a HP-5MS fused silica capillary column (30 m × 0.25 mm inner diameter, Hewlett-Packard). The column head
pressure was maintained at around 8.2 p.s.i. to give a constant
flow rate of 1 ml/min using helium as carrier gas. Initial oven
temperature was held at 60 °C for 1 min, increased to 90 °C in 1 min, and then to 290 °C in 25 min.
Exoglycosidase Digestion--
PA-oligosaccharides were first
digested with 50 milliunits of sialidase (from A. ureafaciens, Roche) in 25 µl of 50 mM sodium acetate
buffer, pH 5.0, for 24 h at 37 °C. Subsequently, samples were
redissolved in 25 µl of 50 mM sodium citrate phosphate
buffer, pH 4.5, and 5 µl of -galactosidase (20 milliunits, from
bovine testes; Roche) was added. After 24 h at 37 °C, 500 milliunits of N-acetyl- -D-hexosaminidase
(from jack bean, Calbiochem) in 20 µl of the same buffer,
pH 5, was added and the incubation was left for another 24 h. The
digestion products were desalted by passing through a Sep-Pak C18
cartridge (Waters), washed with water, and the PA-oligosaccharides were
then eluted with 50% methanol in water.
 |
RESULTS |
Analysis of PEW Proteins on SDS-PAGE and Their Identification by
Partial Peptide Sequencing--
The SDS-PAGE profile of PEW revealed
four major bands, and overall was considerably different from the
profile of chicken egg white (Fig.
1A). N-terminal amino acid
sequencing of PEW proteins separated by SDS-PAGE indicated that the
highest (APQKASVRWXTISSAEEKKXNNLRE) and the
lowest (VEVDXSRYHXTTNVEGREGL) molecular size
proteins of these four were homologous to chicken ovotransferrin (COT) and ovomucoid (COM), respectively. The N termini of the middle two
proteins were fractal to sequencing by Edman degradation. This may be
attributable to N-terminal blockage as in the case of chicken ovalbumin
(COA), which is acetylated at the N terminus. Internal peptide
sequences of the higher (MERKRVKVYLPRM and MPFRVTEQESKPVQM) and lower
(MLYLGARGNTKAQIDKVVHFD and MGLGITDLFSSXADLSGISSV) molecular size proteins indicated high homologies to those of COA.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 1.
Analysis of PEW glycoproteins by SDS-PAGE,
lectin blotting, and immunoblotting. A, profiles of
proteins from pigeon and chicken egg whites by SDS-PAGE. Ten µg of
PEW and CEW were heat-denatured with sample buffer containing 3% SDS
and 5% 2-mercaptoethanol and loaded to a 12.5% polyacrylamide gel as
described under "Experimental Procedures." After electrophoresis,
the gel was stained with CBB. B, detection of -galactosyl
residue on PEW by lectin blotting and immunoblotting. Five µg of
glycoproteins were separated by SDS-PAGE, transferred to PVDF
membranes, and stained with GS-I lectin, anti-P1 mAb, or
anti-(Gal 1-3Gal) mAb. Mouse laminin and its fragments (MLN) are
positive controls for glycoproteins possessing Gal 1-3Gal.
|
|
Accordingly, these four major proteins were designated POT, POA(hi),
POA(lo), and POM, respectively, as shown in Fig. 1A. POM,
like its chicken counterpart, appeared as broad bands, apparently caused by glycan heterogeneity (Fig. 1A). A gross size
heterogeneity has been reported in ovomucoids from chicken (41), quail
(32, 33), duck (34), and turtle dove (21).
Detection of -Galactoside on PEW Proteins by GS-I Lectin,
Anti-P1 mAb, and Anti-(Gal 1-3Gal) mAb--
The bands
of PEW proteins separated by SDS-PAGE were transferred onto PVDF
membrane and stained with alkaline phosphatase-conjugated GS-I lectin,
which binds terminal -Gal residues specifically. All four major
glycoproteins were stained with GS-I lectin, as shown in Fig.
1B. POM showed especially intense bands by GS-I, whereas it
showed only weak bands by staining with Coomassie Brilliant Blue (CBB).
None of the glycoproteins from chicken egg white were stained with GS-I
lectin (data not shown).
These pigeon glycoproteins were also stained positively with
anti-P1 mAb, specific for P1 blood type (Fig.
1B). Mouse laminin, which contains Gal 1-3Gal (42, 43),
was not stained with anti-P1 mAb but was stained with GS-I
lectin (Fig. 1B). On the other hand, the glycoproteins from
PEW were stained with anti-(Gal 1-3Gal) mAb only feebly, whereas
mouse laminin was stained clearly (Fig. 1B). The four major
PEW glycoproteins also did not react with human polyclonal antibody
purified with (Gal 1-3Gal)-Sepharose (tested with microplate-coating
method). These data indicate that all four major glycoproteins from PEW
contain an epitope most likely to be Gal 1-4Gal, but not
Gal 1-3Gal.
Analysis and Isolation of PEW Glycoproteins by HPLC--
PEW was
separated by RP-HPLC eluting with a gradient of acetonitrile. The peaks
corresponding to POM, POT, POA(hi), and POA(lo) were well separated
with both analytical (4.6 × 250 mm) and semipreparative (21.2 × 250 mm) C4 columns (Fig.
2A). The purity of individual peaks was confirmed by SDS-PAGE (Fig. 2B). The contents of
individual proteins (based on A280 nm monitored
during HPLC separation) were POM, 7.49%; POT, 19.5%; POA(hi), 42.3%;
POA(lo), 15.0%. These values are in the same range as their chicken
counterparts: COM, 11%; COT, 12-13%; COA, 54% (44).

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 2.
Separation of PEW glycoproteins by
RP-HPLC. Twenty mg of PEW was loaded onto a RP-HPLC C4 column
(21.2 × 250 mm) and eluted by a gradient of acetonitrile
(A), and individual peaks from the column were collected and
analyzed on SDS-PAGE (B).
|
|
Hemagglutination Assay--
Human P1-erythrocytes were
agglutinated by three different agglutinators: P-fimbriated E. coli strain J96 (PapG class I- and III-positive), GS-I lectin, and
anti-P1 antibody. All three are capable of binding to
P1 antigen, although their specificities are different.
Hemagglutination by type I fimbriae on E. coli was
eliminated in this assay by addition of excess methyl
-D-mannopyranoside. Table
I shows the activities of whole PEW and
individual PEW glycoproteins in inhibiting the hemagglutination. The
inhibitory activities for agglutination mediated by E. coli
or GS-I lectin are indicated as last full inhibition and first full
agglutination as defined under "Experimental Procedures," and for
agglutination mediated by anti-P1 antibody are indicated as
the final concentrations of inhibitors giving detectable inhibition.
Varying degrees of inhibition of hemagglutination by E. coli
strain J96, GS-I, and anti-P1 antibody were observed with
all four PEW glycoproteins as well as with whole PEW, whereas no
inhibition was detected with 12.9 mg/ml BSA. The limited solubility in
PBS of some inhibitors precluded accurate measurement of the
concentration required for full inhibition. POM exhibited the highest
inhibitory activity among PEW glycoproteins against agglutination by
E. coli strain J96, while POA(hi) was a more potent
inhibitor of agglutination mediated by GS-I and anti-P1
antibody. -Galactosidase-treated POM showed a significant reduction
of the hemagglutination inhibitory activity, suggesting that
-galactosyl residues on the glycoprotein are responsible for the
inhibition.
Analysis of Monosaccharide Composition and Release of Galactose by
-Galactosidase--
The monosaccharide composition of HPLC-purified
PEW glycoproteins are shown in Table II.
All four glycoproteins contain GlcNAc, Man, Gal, and NeuAc, which are
commonly found in N-glycans. No Fuc or GalNAc were detected.
POM, POT, and POAs contain more Gal than their chicken counterparts,
whose N-glycans mostly consist of Man and GlcNAc with some
-Gal and NeuAc (30, 31, 45-50). The ratios of GlcN:Man:Gal were
similar among POM, POA(hi), and POA(lo), whereas POT had a lower
content of Gal. POM had more NeuAc than others. -Galactosidase
released 15-18% of total Gal from POM and POAs, and 37.5% of total
Gal from POT. These data provide evidence that the PEW glycoproteins
are rich in terminal -galactosides.
View this table:
[in this window]
[in a new window]
|
Table II
Monosaccharide compositions of PEW glycoproteins
Amount of protein was measured by BCA assay, and composition of
monosaccharides was analyzed by HPAEC. GlcN, D-glucosamine;
Man, D-mannose; Gal, D-galactose; NeuAc,
N-acetylneuraminic acid.
|
|
Release of Oligosaccharides Containing -Galactoside from POT,
POA(hi), POA(lo), and POM by GAF--
Existence of
N-glycans in the four major glycoproteins from PEW were
probed by digestion with GAF. HPLC-separated POT, POA(hi), POA(lo), and
POM were heat-denatured in the presence of 0.5% SDS and incubated with
GAF overnight in the presence of 1% Nonidet P-40. Decrease in
molecular size after GAF digestion (analyzed by SDS-PAGE) was apparent
in all four glycoproteins (data not shown). The shifts in molecular
sizes were smaller for POT than for POA(hi), POA(lo), and POM. The
molecular sizes of the deglycosylated POA(hi) and POA(lo) were still
different from each other. HPLC-purified POM showed at least three
down-shifted bands on SDS-PAGE after digestion with GAF in the presence
of 1% Nonidet P-40, which is suggestive of incomplete deglycosylation
by GAF.
In another experiment, whole PEW was treated with GAF in the presence
of 1% Nonidet P-40, separated by SDS-PAGE, transferred to PVDF
membrane, and stained with CBB or GS-I lectin. POT, POA(hi), and
POA(lo) treated with GAF showed shifts in molecular sizes, and the
deglycosylated POT, POA(hi), and POA(lo) could no longer be stained
with GS-I lectin (data not shown). This indicates oligosaccharides containing -Gal on POT and POAs were completely released by GAF under the conditions used. The POM in the whole PEW treated with GAF
still showed substantial staining with GS-I even after GAF digestion,
possibly due to incomplete deglycosylation.
To achieve complete deglycosylation of POM, HPLC-purified POM was
digested with GAF in the presence of 2% CHAPS instead of Nonidet P-40,
and the GAF treatment was repeated three times. POM exhaustively
digested with GAF in this way revealed only one band (31 kDa) by CBB,
which was not stained by GS-I (data not shown). Thus, it was concluded
that the 31-kDa band has lost all oligosaccharides containing
-galactoside by GAF digestion. The fact that two broad bands of
native POM became a single band by exhaustive GAF digestion indicates
that POM has a varied number of glycosylation sites, such as is found
in the chicken counterpart (51, 52).
Table III shows the data of MALDI-TOF
mass spectrometry for HPLC-separated POM, POT, and POA(hi) before and
after GAF treatment. De-N-glycosylated POA(lo) could not be
analyzed successfully, because of its lower solubility in water in the
absence of detergents. Molecular masses of POT and POA(hi) before and
after GAF-treatment (Table III) were in agreement with the molecular
sizes indicated by the SDS-PAGE, whereas molecular masses of POM, from
mass spectrometric analysis, both before and after GAF treatment, were
much lower than those from the SDS-PAGE method. Intact POM showed two
broad peaks by mass spectrometric analysis, which might represent two distinct states of glycosylation. Similarly, the three different molecular masses of the GAF-treated POM shown by MALDI-TOF mass spectrometry (Table III) are most likely due to the difference in the
residual oligosaccharide chains. The molecular mass values of the
oligosaccharides released by GAF treatment, shown in Table III, were
estimated by subtracting the molecular mass values of GAF-treated
proteins from those of the untreated protein. The content of
oligosaccharides based on the molecular mass values were: POM;
30.8-36.9 (%), POT; 3.51 (%), and POA (hi); 16.5 (%). From the
carbohydrate content of each glycoprotein in PEW, N-linked oligosaccharides in POM, POT, and POA(hi) were deduced to be 23-28, 7, and 70 mg, respectively, in 1 g of whole PEW proteins.
View this table:
[in this window]
[in a new window]
|
Table III
MALDI-TOF of PEW proteins before and after GAF treatment
PEW glycoproteins isolated with HPLC were incubated with (+) or without
( ) GAF as described under "Experimental Procedures."
|
|
Determination of the Number of N-Glycosylation Sites on PEW
Glycoproteins--
To determine the number of N-linked
glycosylation sites on POA(hi), the glycoprotein was partially
de-N-glycosylated by using 0.4 units of GAF with different
incubation times, and completely de-N-glycosylated by using
1 unit of GAF with overnight incubation as described under
"Experimental Procedures." POA(hi) was sequentially deglycosylated
with three intermediates bands on SDS-PAGE between native and
completely deglycosylated proteins (data not shown). This result
indicates that deglycosylation on POA(hi) progressed in four sequential
steps; therefore, it was deduced that four N-linked
glycosylation sites are present in POA(hi). By the same method, three
to four sites in POM, and only one site in POT were deduced (data not
shown). On their chicken counterparts, N-glycosylation sites
are reported to be four to five sites for chicken ovomucoid (51, 52),
one site each for chicken ovotransferrin (53), and chicken ovalbumin
(54, 55). No O-linked oligosaccharides have been detected on
these chicken egg white glycoproteins. The varied number of
glycosylation sites on chicken ovomucoid is attributable to partial
N-glycosylation on Asn175 (51, 52). Similarly
varied numbers of glycosylation sites are also found in POM (Table
III).
Isolation of Major Oligosaccharides from POA(hi) by
HPLC--
Since POA(hi) is the major glycoprotein in PEW and has a
higher carbohydrate content than POT, we investigated the structure of
major oligosaccharides from POA(hi). PA-derivatized oligosaccharides from POA(hi) were separated with anion exchange HPLC on a DEAE column
as the first step (39). As shown in Fig.
3A, neutral, monosialyl,
disialyl, and trisialyl oligosaccharides are separated based on their
charges, and the molar ratio of their fractions was 11.6%, 69.6%,
17.3%, and 1.47%, respectively. The monosialylated fraction, being
the major fraction, was further analyzed and separated with reverse
phase HPLC on an ODS column. As shown in Fig. 3B, the
monosialylated PA-oligosaccharides were separated into more than 10 peaks, suggesting that the oligosaccharides from POA(hi) are highly
heterogeneous. The neutral and disialylated oligosaccharides from the DEAE column were also heterogeneous, according to their elution profiles on the ODS column (data not shown). The five monosialylated major fractions separated on the ODS column were designated as ms-5, ms-7, ms-8, ms-9, and ms-12, and further analyzed with normal phase HPLC on an Amido-80 column (Fig. 3C). The
elution profiles showed that each fraction had a single major peak
designated as ms-5-4, ms-7-1, ms-8-2, ms-9-2, and ms-12-2,
respectively. Contents of these five major fractions on the Amido-80
column were 19.1%, 4.68%, 7.41%, 1.75%, and 7.01% of the total
PA-oligosaccharides from POA(hi), respectively.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 3.
Separation of major PA-oligosaccharides from
POA(hi) by HPLC. A, total PA-oligosaccharides from
POA(hi) were separated to neutral, mono-, di-, and trisialyl
oligosaccharides on a DEAE column. B, the monosialylated
PA-oligosaccharides from the DEAE column were further separated by an
ODS column. C, each of the major monosialylated
PA-oligosaccharides from the ODS column was analyzed by an Amido-80
column.
|
|
Structural Analysis of the PA-tagged Major Oligosaccharides from
POA(hi)--
The structures of each of the major peaks were deduced
based on mass spectrometry analysis of the permethyl derivatives.
Fraction ms-5-4 afforded a single [M + H]+ molecular ion
at m/z 4015 (Table IV) and two
major non-reducing terminal oxonium type fragment ions at
m/z 668 and 825, corresponding to
Hex2HexNAc+ and
NeuAc1Hex1HexNAc+, respectively
(low mass range; data not shown). This is in agreement with the
assignment of a tetra-antennary complex type structure for ms-5-4,
with three antenna being Hex-Hex-HexNAc and a fourth one as
NeuAc-Hex-HexNAc (see Table IV). The other four fractions of lower
abundance, ms-7, ms-8, ms-9, and ms-12, were analyzed directly after
the ODS column, and not after further subfractionation on the Amido-80
column. Each yielded a major molecular ion signal and one or more minor
signals (Table IV). To ascertain the origin of the fragment ions
observed, the major molecular ion signals were subjected to CID-MS/MS
(Fig. 4, A-C). As with
ms-5-4, the [M + H]+ molecular ion of ms-7
(m/z 4669, Fig. 4A) yielded the key daughter ions
at m/z 825 and 668, corresponding to
NeuAc-Hex-HexNAc+ and Hex-Hex-HexNAc+,
respectively. In support of these two non-reducing terminal structures
are the ions at m/z 376 (terminal NeuAc+),
m/z 344 (41 NeuAc+, where 41 denotes elimination
of a CH3OH moiety) and m/z 187 (41 Hex+). In contrast, both the parent ions of ms-8
(m/z 4260, Fig. 4B) and ms-12 (m/z
3606, Fig. 4C) gave an additional daughter ion at
m/z 260 (HexNAc+), indicating the presence of a
terminal HexNAc residue. None yielded daughter ion at m/z
464, suggesting that a terminal Hex-HexNAc unit was not present among
the antenna. The weak parent ion at m/z 4056 in ms-9
afforded only two weak daughter ions at m/z 464 and 668 (data not shown). The molecular composition and the fragment ions
afforded by the major components detected in each fractions by MS
analysis, together with further linkage analysis data and deduced
structures were summarized in Table IV.
View this table:
[in this window]
[in a new window]
|
Table IV
Assignment of the major PA-oligosaccharide structures found in the ODS
column HPLC fractions based on mass
spectrometrya and methylation
analysisb
|
|

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 4.
CID-MS/MS of selected major molecular parent
ions afforded by FAB-MS analysis of the permethyl derivatives of the
PA-oligosaccharides from POA(hi) ms-7 (A), ms-8
(B), and ms-12 (C). Major
daughter ions correspond to A-type non-reducing end oxonium ions,
accompanied by signals at 32 mass units lower resulting from further
elimination of a CH3OH moiety as described by Dell et
al. (40). The insets show the parent ions with an
A-type fragment ion resulting from cleavage between the two GlcNAc of
the chitobiose core. No fragment ion was detected within the mass range
of m/z 1000-3000.
|
|
Notably, methylation analysis by GC-EI-MS demonstrated that all
fractions contained terminal Gal, 4-linked Gal, and 6-linked Gal. The
former two were consistent with the deduced terminal Gal 1-4Gal
epitope, whereas the last suggested that the single NeuAc residue was
2,6-linked to Gal. The major difference among the various fractions
analyzed was found to be the Man residues detected. The presence of
2,4- and 2,6-linked Man in ms-5, ms-8, and ms-9 is consistent with a
tetra-antennary structure whereas the presence of a 2,4,6-linked Man
instead of a 2,6-Man in ms-7 supported a pentaantennary structure, and
the presence of a 2-linked Man instead of a 2,6-linked Man in ms-12 is
consistent with a triantennary structure. The latter triantennary
structure, with a single antennae on the 6-arm, resulted in its later
elution time than the others on an ODS column (56). In addition, the presence of a bisecting GlcNAc in fractions ms-8, ms-9, and ms-12 was
indicated by the presence of 3,4,6-linked Man instead of 3,6-linked Man, which also contributed to their longer retention time on an ODS
column than ms-5 and ms-7. In short, the structural analysis data are
fully consistent with the HPLC elution time of each sample, which also
suggested that the single monosialylated antennae is probably located
on the same position for each N-glycan.
To further define the location of the monosialylated antennae, ms-5-4
and ms-7 were sequentially digested with neuraminidase from A. ureafaciens, -galactosidase from bovine testes, and
-N-acetylhexosaminidase from jack bean. ESI-MS analysis
of the permethyl derivatives of the digestion products (Fig.
5) showed that one
NeuAc 2-6Gal 1-4GlcNAc 1- antennae was completely removed to
yield a predominant product with a molecular composition of one NeuAc,
one Hex, and one HexNAc residues less than the undigested samples. The
results also further confirmed that the other antenna were capped by an
-Gal residue, which rendered them resistant to -galactosidase
digestion. Upon removal of the sialylated antennae, linkage analysis of
the digestion products showed that 6-linked Gal and 2,4-linked Man in
both ms-5-4 and ms-7 have disappeared (data not shown). Since 2-linked
Man was not detected, whereas 4-linked Man co-eluted with 4-linked Gal,
it was concluded that the single sialylated antennae was located on the
GlcNAc 2-linked to the Man on the 3-arm. This antennae (i.e.
-GlcNAc1-2Man1-3Man-) is in fact commonly present in all tri-,
tetra-, and pentaantennary structures. Due to the presence of other
minor components and the incompleteness of digestion resulting from the
steric hindrance imposed by the bisecting GlcNAc, the location of the
sialylated antennae could not be conclusively demonstrated for other
fractions (ms-8, ms-9, and ms-10).

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 5.
ESI-MS analysis of the exo-glycosidases
treated permethyl derivatives of ms-5-4 (A) and ms-7
(B) from POA(hi). The insets show the
disodiated doubly charged molecular ions acquired with a separate scan.
At high cone voltage used to acquire the MS data, several fragment ions
due to sequential loss of non-reducing terminal residues from the
singly charged sodiated molecular ion could also be detected (signals
between m/z 2000 and 3000 in A). By virtue of
mass difference, these could be differentiated from the genuine
presence of other molecular ion signals corresponding to components
with more antenna having trimmed off by the -galactosidase and/or
-N-acetylhexosaminidase digestions. Thus, signals at
m/z 3225 and 2571 in B correspond, respectively,
to components with two and three antenna completely removed. These
could originate from minor components with incomplete
-galactosylated Gal 1-4GlcNAc - or GlcNAc1 - on one or more
antenna.
|
|
 |
DISCUSSION |
Although POM as well as the whole PEW manifested P1
antigenic activity and inhibit adherence of uropathogenic E. coli (24-26), it was not known whether the antigenicity of PEW is
derived solely from POM or from other PEW glycoproteins also. We
demonstrated that, in addition to POM, other major glycoproteins (POT,
POA(hi), and POA(lo)) also contain terminal Gal 1-4Gal, but none of
them contain Gal 1-3Gal as expressed most commonly in mammals. These data suggest that the synthetic mechanisms to produce Gal 1-4Gal in
pigeon is not limited to the N-glycan of POM, but is also
operative for the other PEW glycoproteins. Since synthesis and glycosyl modification of egg white glycoproteins are mostly carried out in the
oviduct, the Gal 1-4Gal linkages may also be formed in this organ.
The presence of Gal 1-4Gal on the PEW glycoproteins can explain the
inhibitory activities of the glycoproteins for P-fimbriated E. coli. That POAs and POT, like POM, specifically inhibit binding of
P fimbriae of uropathogenic E. coli suggest that they also can bind to some other pathogenic bacterial adhesins and enterotoxins, which recognize Gal 1-4Gal. Different PEW glycoproteins showed somewhat different inhibitory potency against three different agglutinators (Table I). This may reflect the different amounts and the structures of the carbohydrates in the individual
glycoproteins, and the different carbohydrate-binding specificities
among the agglutinators.
We have demonstrated that the -galactoside-containing
oligosaccharides on POT, POA(hi), POA(lo), and POM exist only as
N-glycans. The molecular masses of
de-N-glycosylated polypeptide chains of POM, POT, and
POA(hi) measured by MALDI-TOF-MS (Table III) were in the range of the
masses of the peptide portions of chicken counterparts (as calculated
from the peptide sequences), COM (20,098), COT (75,827), and COA
(42,750), respectively, although the mass of POA(hi) is about 2 kDa
higher than COA. The MS data also indicated that the differences of
molecular sizes between the intact glycoproteins from PEW and CEW were
mostly due to the glycosylation. In other words, PEW proteins contain
more carbohydrates than their chicken counterparts.
Intriguingly, two POAs of distinctly different sizes were found in PEW,
whereas only one species of ovalbumin (excluding heterogeneities due to
phosphorylation and carbohydrate structures) is expressed in CEW. The
difference in the molecular sizes between POA(hi) and POA(lo), about 5 kDa from MALDI-TOF-MS, is not attributable to glycosylation, because
the molecular mass difference persists after deglycosylation (data not
shown). During the isolation and sequence analyses of glycopeptides
from POA(hi) and POA(lo), we have found they are homologous but not
identical in their peptide sequences suggesting that these POAs are
expressed from different but related genes (data not shown).
The monosaccharide compositions were different among POM,
POT, and POAs (Table II), suggesting that the carbohydrate structures on these glycoproteins are not equal, as found in the case of CEW
glycoproteins. N-Glycans on COM, COT, and COA, have quite variable ratios of bi-, tri-, tetra-, and penta-antennary
oligosaccharides (30, 31, 45-50), although all are produced in
oviducts. This also is the case for POT, POM, POA(hi), and POA(lo),
as shown in the accompanying article (57).
The heterogeneity of N-glycans from POA(hi) was evident by
HPLC and subsequent MS analysis for their structures. The data indicated that the glycoform heterogeneity of POA(hi) resulted mainly
from the presence of 1) a mixture of tri-, tetra-, and pentaantennary
complex type structures; 2) bisecting GlcNAc on the -Man among a
subpopulation; and 3) different degrees of sialylation. The extensive
heterogeneity makes complete characterization of all glycoforms a
laborious and daunting task (57). The presence of tri- and
tetra-antennary structures as the major N-glycans suggests
that POA(hi) has complex population of N-glycans from those
of turtle dove ovomucoid, whose proposed structures were pentaantennary
(28, 29). In the following paper (57), we have studied 25 structures of PA-derivatized N-glycans of POT, POAs, and
POM, and found that the exact structure proposed for the turtle dove
ovomucoid is not present in the major PEW glycoproteins.
MS analysis for the structures of major N-glycans from
POA(hi) also suggested the presence of Gal 1-4Gal and the absence of Gal 1-3Gal in all the analyzed oligosaccharides as predicted by the
data of immunostaining (Fig. 1B). However, the structural feature of the analyzed N-glycans from POA(hi),
i.e. occupation of non-reducing termini by either
1,4-galactosides or 2,6-sialic acids, are quite similar to
N-glycans containing Gal 1-3Gal produced in mammals,
e.g. N-glycan from bovine thyroglobulin (58).
Formation of Gal 1-3Gal on N-glycans expressed in
mammalian cells is considered to reduce sialylation on non-reducing
Gal 1-4GlcNAc terminal in vivo (59).
Gal 1-4Gal 1-4GlcNAc in pigeon can be speculated to have an
effect on sialylation similar to that of Gal 1-3Gal in mammals.
The presence of Gal 1-4Gal or substances similar to P1
antigen only in some avian species is phylogenetically interesting. It
was reported that P1 antigenic activities is absent in the blood of chicken, gander, turkey, quail, duck, and pheasant (22, 60),
and no -galactoside is found in the glycans of ovomucoid from
chicken, quail, and duck (30-34). On the other hand, P1
antigenic activities have been reported to be present in the blood
and/or eggs of pigeon, turtle dove, budgerigar, and cockatiel (23, 24,
60). Interestingly, salivary gland mucin glycoproteins of Chinese
swiftlets (genus Collocalia) contain O-linked
glycans with Gal 1-4Gal 1-4Gal (61). These reports suggest that
Gal 1-4Gal is absent in the orders Galliformes (chicken, turkey,
quail, and pheasant) and Anseriformes (duck and gander), but present in
the orders Columbiformes (pigeon and turtle dove), Psittaciformes (budgerigar and cockatiel), and Apodiformes (swiftlet) (62), based on
the limited information available. Galliformes and Anseriformes were
regarded as sister taxa by morphological analyses (63), nuclear DNA-DNA
hybridization analyses (64), and mitochondrial DNA sequence analyses
(65), and this sister group was placed as branched group from most of
the other groups of modern birds including Columbiformes,
Psittaciformes, and Apodiformes. Therefore, it is possible that, in the
course of evolution and diversification of the modern birds, some of
the avian species acquired (e.g. ancestor of Columbiformes,
Psittaciformes, and Apodiformes) or lost (e.g. ancestor of
Galliformes and Anseriformes) the ability to express Gal 1-4Gal,
because of some selective pressures. Distribution of Gal 1-4Gal
among birds and its phylogenic relationships will be refined by further
investigation into whether birds of other orders also produce
glycoproteins with Gal 1-4Gal.
The real biological significance of Gal 1-4Gal in pigeon is unknown
at this stage, although one possibility is defense against microbial
infection. Our recent data indicated that pigeon serum and liver
extracts also contain glycoproteins showing the presence of
Gal 1-4Gal, by SDS-PAGE and Western blot with GS-I and
anti-P1 mAb. This suggests that the putative function of
Gal 1-4Gal may not be limited to some specific organs in pigeon, but
may be required for the entire body. Study of genetic control and
enzymatic behavior of -1,4-galactosyltransferase, which is
responsible for production of Gal 1-4Gal in pigeon, would be one of
the ways to understand the evolution of glycoproteins.
Furthermore, the demonstration that Gal 1-4Gal sequence is
abundantly present in pigeon egg white glycoproteins led us to utilize
these unique features for biomedical applications. We have constructed
microbeads bearing PEW glycoproteins, and they agglutinate the strains
of E. coli that have P-fimbriae (data not included). The
beads can be utilized as diagnostic reagents to determine bacteria or
toxins with the specificity. In addition, Sepharose beads bearing these
glycoproteins have been successfully used to isolate Shiga-like toxin,
which recognized galabiose structure (66). The potential of PEW
glycoproteins as biomedical tools will expand to use as a therapeutic
agent to prevent or treat urinary tract infections due to E. coli.
 |
ACKNOWLEDGEMENTS |
We are grateful for Dr. Noboru Tomiya for
technical advice concerning purification of oligosaccharides by HPLC,
we acknowledge the technical assistance of Timothy O'Bryan and
Claudine Fasching for preparation of PEW and experiments of
hemagglutination assay, and we thank Dave Revoir and other pigeon
breeders in the Minneapolis-St. Paul area who provided pigeon eggs.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Research Grant DKO9970 (to N. S. and Y. C. L.), a grant
from Academia Sinica (to K.-H. K.), a Department of Veterans
Affairs Merit Review (to J. R. J.), and National Institutes
of Health Grant DK-47504 (to J. R. J.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
**
To whom correspondence should be addressed. Tel.: 410-516-7041;
Fax: 410-516-8716; E-mail: yclee@jhu.edu.
Published, JBC Papers in Press, April 3, 2001, DOI 10.1074/jbc.M101379200
2
Glycoamidase F is also known as PNGase F,
glycopeptide N-glycosidase F, or
N-glycanase.
 |
ABBREVIATIONS |
The abbreviations used are:
POM, pigeon
ovomucoid;
BSA, bovine serum albumin;
CAPS, 3-(cyclohexylamino)propanesulfonic acid;
CBB, Coomassie Brilliant
Blue;
CEW, chicken egg white;
CID, collision-induced dissociation;
COA, chicken ovalbumin;
COM, chicken ovomucoid;
COT, chicken ovotransferrin;
ESI, electrospray;
FAB, fast atom/ion bombardment;
GAF, glycoamidase F;
GC-EI, gas chromatography-electron impact;
Hex, hexose;
HexNAc, N-acetylhexosamine;
MALDI, matrix-assisted laser
desorption/ionization;
mAb, monoclonal antibody;
MS, mass spectrometry;
NeuAc, N-acetylneuraminic acid;
ODS, octadecylsilica;
PA, pyridylamine;
PBS, phosphate-buffered saline;
PEW, pigeon egg white;
POA, pigeon ovalbumin;
POT, pigeon ovotransferrin;
RBC, red blood cell;
TBS, Tris-buffered saline;
TBST, Tris-buffered saline with Tween 20;
TOF, time of flight;
RP, reverse phase;
HPLC, high performance liquid
chromatography;
HPAEC, high performance anion exchange chromatography;
PVDF, polyvinylidene difluoride;
PAD, pulsed amperometric detector;
CHAPS, 3-[(3-cholamidopro-pyl)dimethylammonio]-1-propanesulfonic
acid;
PAGE, polyacrylamide gel electrophoresis.
 |
REFERENCES |
| 1.
|
Yang, Z.,
Bergstrom, J.,
and Karlsson, K. A.
(1994)
J. Biol. Chem.
269,
14620-14624
|
| 2.
|
Kotani, M.,
Kawashima, I.,
Ozawa, H.,
Ogura, K.,
Ariga, T.,
and Tai, T.
(1994)
Arch. Biochem. Biophys.
310,
89-96
|
| 3.
|
Nakamura, K.,
Fujita, R.,
Ueno, K.,
and Handa, S.
(1984)
J. Biochem. (Tokyo)
95,
1137-1144
|
| 4.
|
Lyerla, T. A.,
Gross, S. K.,
and McCluer, R. H.
(1986)
J. Cell. Physiol.
129,
390-394
|
| 5.
|
Gahmberg, C. G.,
and Hakomori, S.
(1975)
J. Biol. Chem.
250,
2438-2446
|
| 6.
|
Stapleton, A.,
Nudelman, E.,
Clausen, H.,
Hakomori, S.,
and Stamm, W. E.
(1992)
J. Clin. Invest.
90,
965-972
|
| 7.
|
Stapleton, A. E.,
Stroud, M. R.,
Hakomori, S. I.,
and Stamm, W. E.
(1998)
Infect. Immun.
66,
3856-3861
|
| 8.
|
Stroud, M. R.,
Stapleton, A. E.,
and Levery, S. B.
(1998)
Biochemistry
37,
17420-17428
|
| 9.
|
Korhonen, T. K.,
Vaisanen, V.,
Saxen, H.,
Hultberg, H.,
and Svenson, S. B.
(1982)
Infect. Immun.
37,
286-291
|
| 10.
|
Bock, K.,
Breimer, M. E.,
Brignole, A.,
Hansson, G. C.,
Karlsson, K. A.,
Larson, G.,
Leffler, H.,
Samuelsson, B. E.,
Stromberg, N.,
Eden, C. S.,
and Thurin, J.
(1985)
J. Biol. Chem.
260,
8545-8551
|
| 11.
|
Gilboa-Garber, N.,
Sudakevitz, D.,
Sheffi, M.,
Sela, R.,
and Levene, C.
(1994)
Glycoconjugate J.
11,
414-417
|
| 12.
|
Haataja, S.,
Tikkanen, K.,
Liukkonen, J.,
François-Gérard, C.,
and Finne, J.
(1993)
J. Biol. Chem.
268,
4311-4317
|
| 13.
|
Tikkanen, K.,
Haataja, S.,
and Finne, J.
(1996)
Infect. Immun.
64,
3659-3665
|
| 14.
|
Tikkanen, K.,
Haataja, S.,
François-Gérard, C.,
and Finne, J.
(1995)
J. Biol. Chem.
270,
28874-28878
|
| 15.
|
Lingwood, C. A.,
Law, H.,
Richardson, S.,
Petric, M.,
Brunton, J. L.,
De Grandis, S.,
and Karmali, M.
(1987)
J. Biol. Chem.
262,
8834-8839
|
| 16.
|
Lindberg, A. A.,
Brown, J. E.,
Stromberg, N.,
Westling-Ryd, M.,
Schultz, J. E.,
and Karlsson, K. A.
(1987)
J. Biol. Chem.
262,
1779-1785
|
| 17.
|
Chatterjee, S.,
Khullar, M.,
and Shi, W. Y.
(1995)
Glycobiology
5,
327-333
|
| 18.
|
Khoo, K. H.,
Nieto, A.,
Morris, H. R.,
and Dell, A.
(1997)
Mol. Biochem. Parasitol.
86,
237-248
|
| 19.
|
Russi, S.,
Siracusano, A.,
and Vicari, G.
(1974)
J. Immunol.
112,
1061-1069
|
| 20.
|
Cossey, A.,
Dimichiel, A.,
and Dunstone, J.
(1979)
Eur. J. Biochem.
98,
53-60
|
| 21.
|
François-Gérard, C.,
Gerday, C.,
and Beeley, J. G.
(1979)
Biochem. J.
177,
679-685
|
| 22.
|
François-Gérard, C.,
Brocteur, J.,
and André, A.
(1980)
Vox Sang.
39,
141-148
|
| 23.
|
François-Gérard, C.,
and Brocteur, J.
(1980)
Rev. Fr. Transf. Immunohemat.
23,
95-102
|
| 24.
|
Johnson, J. R.,
Swanson, J. L.,
and Neill, M. A.
(1992)
Infect. Immun.
60,
578-583
|
| 25.
|
Johnson, J. R.,
and Ross, A. E.
(1993)
Infect. Immun.
61,
4902-4905
|
| 26.
|
Johnson, J. R.,
and Berggren, T.
(1994)
Am. J. Med. Sci.
307,
335-339
|
| 27.
|
Miyake, M.,
Utsuno, E.,
and Noda, M.
(2000)
Anal. Biochem.
281,
202-208
|
| 28.
|
François-Gérard, C.,
Brocteur, J.,
André, A.,
Gerday, C.,
Pierce-Cretel, A.,
Montreuil, J.,
and Spik, G.
(1980)
Rev. Fr. Transf. Immunohemat.
23,
579-588
|
| 29.
|
François-Gérard, C.,
Pierce-Cretel, A.,
André, A.,
Dorland, L.,
van Halbeek, H.,
Vliegenthart, J. F. G.,
Montreuil, J.,
and Spik, G.
(1983)
in
Proceedings of the 7th International Symposium on Glycoconjugates
(Chester, M. A.
, Heinegard, D.
, Lundblad, A.
, and Svensson, S., eds)
, pp. 169-170, Rahms, Lund, Sweden
|
| 30.
|
Yamashita, K.,
Kamerling, J. P.,
and Kobata, A.
(1982)
J. Biol. Chem.
257,
12809-12814
|
| 31.
|
Yamashita, K.,
Kamerling, J. P.,
and Kobata, A.
(1983)
J. Biol. Chem.
258,
3099-3106
|
| 32.
|
Hase, S.,
Okawa, K.,
and Ikenaka, T.
(1982)
J. Biochem. (Tokyo)
91,
735-737
|
| 33.
|
Hase, S.,
Sugimoto, T.,
Takemoto, H.,
Ikenaka, T.,
and Schmid, K.
(1986)
J. Biochem. (Tokyo)
99,
1725-1733
|
| 34.
|
Takahashi, N.,
Matsuda, T.,
Shikami, K.,
Shimada, I.,
Arata, Y.,
and Nakamura, R.
(1993)
Glycoconj. J.
10,
425-434
|
| 35.
|
Galili, U.,
LaTemple, D. C.,
and Radic, M. Z.
(1998)
Transplantation
65,
1129-1132
|
| 36.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685
|
| 37.
|
Fan, J.-Q.,
Namiki, Y.,
Matsuoka, K.,
and Lee, Y. C.
(1994)
Anal. Biochem.
219,
375-378
|
| 38.
|
Tomiya, N.,
Awaya, J.,
Kurono, M.,
Endo, S.,
Arata, Y.,
and Takahashi, N.
(1988)
Anal. Biochem.
171,
73-90
|
| 39.
|
Nakagawa, H.,
Kawamura, Y.,
Kato, K.,
Shimada, I.,
Arata, Y.,
and Takahashi, N.
(1995)
Anal. Biochem.
226,
130-138
|
| 40.
|
Dell, A.,
Reason, A. J.,
Khoo, K.-H.,
Panico, M.,
McDowell, R. A.,
and Morris, H. R.
(1994)
Methods Enzymol.
230,
108-132
|
| 41.
|
Beeley, J. G.
(1971)
Biochem. J.
123,
399-405
|
| 42.
|
Arumugham, R. G.,
Hsieh, T. C.,
Tanzer, M. L.,
and Laine, R. A.
(1986)
Biochim. Biophys. Acta
883,
112-126
|
| 43.
|
Fujiwara, S.,
Shinkai, H.,
Deutzmann, R.,
Paulsson, M.,
and Timpl, R.
(1988)
Biochem. J.
252,
453-461
|
| 44.
|
Awade, A. C.
(1996)
Z. Lebensm. Unters. Forsch.
202,
1-14
|
| 45.
|
Yamashita, K.,
Tachibana, Y.,
and Kobata, A.
(1978)
J. Biol. Chem.
253,
3862-3869
|
| 46.
|
Yamashita, K.,
Tachibana, Y.,
Hitoi, A.,
and Kobata, A.
(1984)
Carbohydr. Res.
130,
271-288
|
| 47.
|
Spik, G.,
Fournet, B.,
and Montreuil, J.
(1979)
C. R. Acad. Sci. (Paris)
288,
967-970
|
| 48.
|
Dorland, L.,
Haverkamp, J.,
Vliegenthart, J. F.,
Spik, G.,
Fournet, B.,
and Montreuil, J.
(1979)
Eur. J. Biochem.
100,
569-574
|
| 49.
|
Corradi,
Da Silva, M. L.,
Stubbs, H. J.,
Tamura, T.,
and Rice, K. G.
(1995)
Arch. Biochem. Biophys.
318,
465-475
|
| 50.
|
Chen, L. M.,
Yet, M. G.,
and Shao, M. C.
(1988)
FASEB J.
2,
2819-2824
|
| 51.
|
Beeley, J. G.
(1976)
Biochem. J.
159,
335-345
|
| 52.
|
Kato, I.,
Schrode, J.,
Kohr, W. J.,
and Laskowski, M., Jr.
(1987)
Biochemistry
26,
193-201
|
| 53.
|
Williams, J.
(1968)
Biochem. J.
108,
57-67
|
| 54.
|
Lee, Y. C.,
and Montgomery, R.
(1962)
Arch. Biochem. Biophys.
97,
9-17
|
| 55.
|
Nisbet, A. D.,
Saundry, R. H.,
Moir, A. J.,
Fothergill, L. A.,
and Fothergill, J. E.
(1981)
Eur. J. Biochem.
115,
335-345
|
| 56.
|
Tomiya, N.,
and Takahashi, N.
(1998)
Anal. Biochem.
264,
204-210
|
| 57.
|
Takahashi, N.,
Khoo, K. H.,
Suzuki, N.,
Johnson, J. R.,
and Lee, Y. C.
(2001)
J. Biol. Chem.
276,
23230-23239
|
| 58.
|
Dorland, L.,
van Halbeek, H.,
and Vliegenthart, J. F.
(1984)
Biochem. Biophys. Res. Commun.
122,
859-866
|
| 59.
|
Smith, D. F.,
Larsen, R. D.,
Mattox, S.,
Lowe, J. B.,
and Cummings, R. D.
(1990)
J. Biol. Chem.
265,
6225-6234
|
| 60.
|
Brocteur, J.,
François-Gérard, C.,
André, A.,
Radermecker, M.,
Bruwier, M.,
and Salmon, J.
(1975)
Haematologia
9,
43-47
|
| 61.
|
Wieruszeski, J. M.,
Michalski, J. C.,
Montreuil, J.,
Strecker, G.,
Peter- Katalinic, J.,
Egge, H.,
van Halbeek, H.,
Mutsaers, J. H.,
and Vliegenthart, J. F.
(1987)
J. Biol. Chem.
262,
6650-6657
|
| 62.
|
Howard, R.,
and Moore, A.
(1991)
A Complete Checklist of the Birds of the World
, 2nd Ed.
, Academic Press, London
|
| 63.
|
Cracraft, J.
(1986)
Paleobiology
12,
383-399
|
| 64.
|
Sibley, C. G.,
and Ahlquist, J. E.
(1990)
Phylogeny and Classification of Birds: A Study in Molecular Evolution
, Yale University Press, New Haven
|
| 65.
|
Mindell, D. P.,
Sorenson, M. D.,
Huddleston, C. J.,
Miranda, H. C.,
Knight, A.,
Sawchuk, S. J.,
and Yuri, T.
(1997)
in
Avian Molecular Evolution and Systematics
(Mindell, D. P., ed)
, pp. 213-247, Academic Press, San Diego
|
| 66.
| Tomoda, H., Arai, M., Koyama, N., Matsui, H., Obata, R., Lee, Y. C., and Omura, S. (2001) 121st Annual Meeting of the
Pharmaceutical Society of Japan, Sapporo, Japan, p. 77, Abstr. 74
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. Suzuki, T.-H. Su, S.-W. Wu, K. Yamamoto, K.-H. Khoo, and Y. C Lee
Structural analysist of N-glycans from gull egg white glycoproteins and egg yolk IgG
Glycobiology,
July 1, 2009;
19(7):
693 - 706.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Nilsson, W. E. Thomas, E. Trintchina, V. Vogel, and E. V. Sokurenko
Catch Bond-mediated Adhesion without a Shear Threshold: TRIMANNOSE VERSUS MONOMANNOSE INTERACTIONS WITH THE FimH ADHESIN OF ESCHERICHIA COLI
J. Biol. Chem.,
June 16, 2006;
281(24):
16656 - 16663.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Suzuki, M. Laskowski, Jr., and Y. C. Lee
Phylogenetic expression of Gal{alpha}1-4Gal on avian glycoproteins: Glycan differentiation inscribed in the early history of modern birds
PNAS,
June 15, 2004;
101(24):
9023 - 9028.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Suzuki and Y. C. Lee
Site-specific N-glycosylation of chicken serum IgG
Glycobiology,
March 1, 2004;
14(3):
275 - 292.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Loganathan, H. C. Winter, W. J. Judd, J. Petryniak, and I. J. Goldstein
Immobilized Marasmius oreades agglutinin: use for binding and isolation of glycoproteins containing the xenotransplantation or human type B epitopes
Glycobiology,
December 1, 2003;
13(12):
955 - 960.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Suzuki, K.-H. Khoo, C.-M. Chen, H.-C. Chen, and Y. C. Lee
N-Glycan Structures of Pigeon IgG: A MAJOR SERUM GLYCOPROTEIN CONTAINING Gal{alpha}1-4Gal TERMINI
J. Biol. Chem.,
November 21, 2003;
278(47):
46293 - 46306.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Takahashi, K.-H. Khoo, N. Suzuki, J. R. Johnson, and Y. C. Lee
N-Glycan Structures from the Major Glycoproteins of Pigeon Egg White. PREDOMINANCE OF TERMINAL Galalpha (1)Gal
J. Biol. Chem.,
June 22, 2001;
276(26):
23230 - 23239.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|